Trade Ionis Pharmaceuticals, Inc. - IONS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.28 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 35.49 |
| Open | 35.33 |
| 1-Year Change | -29.71% |
| Day's Range | 35.01 - 36.23 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | 35.56 | -0.06 | -0.17% | 35.62 | 36.26 | 34.86 |
| Dec 19, 2024 | 35.49 | -0.88 | -2.42% | 36.37 | 36.68 | 35.32 |
| Dec 18, 2024 | 36.06 | -1.28 | -3.43% | 37.34 | 37.74 | 35.73 |
| Dec 17, 2024 | 37.63 | 0.67 | 1.81% | 36.96 | 38.14 | 36.96 |
| Dec 16, 2024 | 37.92 | 1.61 | 4.43% | 36.31 | 38.72 | 36.26 |
| Dec 13, 2024 | 36.49 | -0.21 | -0.57% | 36.70 | 37.12 | 36.45 |
| Dec 12, 2024 | 36.91 | -0.66 | -1.76% | 37.57 | 37.98 | 36.77 |
| Dec 11, 2024 | 37.81 | -0.11 | -0.29% | 37.92 | 38.50 | 37.41 |
| Dec 10, 2024 | 38.15 | 0.05 | 0.13% | 38.10 | 38.94 | 37.85 |
| Dec 9, 2024 | 38.49 | -0.23 | -0.59% | 38.72 | 40.02 | 38.32 |
| Dec 6, 2024 | 37.96 | 1.32 | 3.60% | 36.64 | 38.52 | 36.51 |
| Dec 5, 2024 | 36.59 | -0.30 | -0.81% | 36.89 | 37.53 | 35.75 |
| Dec 4, 2024 | 37.10 | 1.87 | 5.31% | 35.23 | 37.13 | 35.14 |
| Dec 3, 2024 | 35.75 | 0.15 | 0.42% | 35.60 | 35.96 | 35.08 |
| Dec 2, 2024 | 35.92 | 0.10 | 0.28% | 35.82 | 36.30 | 35.39 |
| Nov 29, 2024 | 35.55 | 0.22 | 0.62% | 35.33 | 36.23 | 34.81 |
| Nov 27, 2024 | 35.76 | 0.47 | 1.33% | 35.29 | 36.31 | 34.72 |
| Nov 26, 2024 | 35.17 | -0.13 | -0.37% | 35.30 | 35.74 | 34.95 |
| Nov 25, 2024 | 35.27 | 0.87 | 2.53% | 34.40 | 36.30 | 34.17 |
| Nov 22, 2024 | 33.84 | 0.28 | 0.83% | 33.56 | 34.68 | 33.56 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Ionis Pharmaceuticals Company profile
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein. It is also developing inotersen, an antisense drug Ionis to treat patients with hereditary transthyretin amyloidosis; and volanesorsen, an antisense drug for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy. In addition, the company is developing drugs for various indications, such as cardiometabolic diseases caused by lipid disorders; cardiovascular disease, clotting disorders, and Alzheimer's and Parkinson's diseases; and acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington's disease. Ionis Pharmaceuticals, Inc. has a collaboration agreement with AstraZeneca to discover and develop antisense therapies for treating cardiovascular and metabolic diseases, and cancer; and Biogen Inc. to develop and commercialize therapies for neurological disorders, SMA, and neurodegenerative diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.| Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com